valsartan ratiopharm 160 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - valsartanum - tabletti, kalvopäällysteinen - 160 mg - valsartaani
tadalafil ratiopharm 2.5 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - tadalafilum - tabletti, kalvopäällysteinen - 2.5 mg - tadalafiili
omeprazol ratiopharm 20 mg enterokapseli, kova
ratiopharm gmbh - omeprazole - enterokapseli, kova - 20 mg - omepratsoli
omeprazol ratiopharm 10 mg enterokapseli, kova
ratiopharm gmbh - omeprazole - enterokapseli, kova - 10 mg - omepratsoli
omeprazol ratiopharm 40 mg enterokapseli, kova
ratiopharm gmbh - omeprazole - enterokapseli, kova - 40 mg - omepratsoli
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
alfuzosin hydrochlorid ratiopharm 10 mg depottabletti
ratiopharm gmbh - alfuzosin hydrochloride - depottabletti - 10 mg - alfutsosiini
letrozol ratiopharm 2.5 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - letrozole - tabletti, kalvopäällysteinen - 2.5 mg - letrotsoli
imatinib ratiopharm 100 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - imatinib mesylate - tabletti, kalvopäällysteinen - 100 mg - imatinibi
imatinib ratiopharm 400 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - imatinib mesylate - tabletti, kalvopäällysteinen - 400 mg - imatinibi